Electroencephalographic Characteristics of Chronic Pain in Patients With Spinal Cord Injury
Unknown statusNot applicableNCT06531837
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The diagnosis of chronic pain currently lacks objective and quantifiable biomarkers. This study aims to observe the EEG characteristics of patients with chronic pain following spinal cord injury and subsequently administer analgesic interventions with remifentanil, esketamine, flurbiprofen, and spinal cord stimulation. The correlation between EEG features and pain intensity will be examined. The research aims to advance the objectification of chronic pain diagnosis and treatment.
Study details
- Official title
- Electroencephalographic Characteristics of Chronic Pain in Patients With Spinal Cord Injury: an Exploratory, Interventional, Non-randomized Controlled Study
- Conditions
- Interventions
- Drug: Esketamine(Continuous infusion)
- Drug: Remifentanil (Target-Controlled Infusion)
- Drug: Flurbiprofen (Single intravenous injection)
- Device: Spinal Cord Stimulation
- Other: No intervention
- Sponsor
- Beijing Tiantan Hospital
- Start date
- 2024-08-25
- Primary completion
- 2026-01-31
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Spinal Cord Injury Patients With Chronic Pain Inclusion Criteria: * Age 18 - 65 years old; * American Society of Anesthesiologists (ASA) I-III; * Dextromanual; * Chronic Pain following Spinal Cord Injury; * Spinal cord electrical stimulator implantation under general anesthesia; * Signed informed consent. Exclusion Criteria: * People with mental and behavioral disorders. * Previous history of craniocerebral disease; * History of drug and alcohol abuse; * Patients with aphasia or inability to cooperate with the pain assessments; * Previous adverse reaction to esketamine, opioids or NSAIDs; * Known sever insufficiency of vitals(such as heart failure/renal dysfunction/hepatic failure); * Patients with myasthenia gravis, bronchial asthma, or a predisposition to respiratory depression; * Bleeding tendency; * BMI ≥ 35 kg/m²; * Pregnancy or lactation. Spinal Cord Injury Patients Without Pain Inclusion Criteria: * Age 18 - 65 years old; * American Society of Anesthesiologists (ASA) I-III; * Dextromanual; * Spinal Cord Injury Patients Without Pain; * Spinal cord electrical stimulator implantation under general anesthesia; * Signed informed consent. Exclusion Criteria: * People with mental and behavioral disorders. * Previous history of craniocerebral disease; * History of drug and alcohol abuse; * Patients with aphasia or inability to cooperate with the pain assessments; * Previous adverse reaction to esketamine, opioids or NSAIDs; * Known sever insufficiency of vitals(such as heart failure/renal dysfunction/hepatic failure); * Patients with myasthenia gravis, bronchial asthma, or a predisposition to respiratory depression; * Bleeding tendency; * BMI ≥ 35 kg/m²; * Pregnancy or lactation.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06531837